Transcode Therapeutics, Inc. Increase (Decrease) in Interest Payable, Net
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2023-03-31
- Transcode Therapeutics, Inc. increase (decrease) in interest payable, net for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- Transcode Therapeutics, Inc. increase (decrease) in interest payable, net for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Transcode Therapeutics, Inc. increase (decrease) in interest payable, net for the quarter ending 2021-06-30 was $22.46K.
- Transcode Therapeutics, Inc. increase (decrease) in interest payable, net for the quarter ending 2021-03-31 was $33.14K.
- Transcode Therapeutics, Inc. increase (decrease) in interest payable, net for fiscal 2021 was $55.60K, a 54.32% decline from fiscal 2020.
- Transcode Therapeutics, Inc. increase (decrease) in interest payable, net for fiscal 2020 was $121.71K.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $22.46K derived: sum of 3 quarters · filed 2023-03-31 | $55.60K 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $22.46K derived: sum of 2 quarters · filed 2022-11-14 | $55.60K 10-Q · filed 2022-11-14 | $89.42K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $22.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $55.60K 10-Q · filed 2022-08-15 | $89.42K derived: sum of 3 quarters · filed 2022-08-15 | $123.24K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $33.14K 10-Q · filed 2022-05-16 | $66.96K derived: sum of 2 quarters · filed 2022-05-16 | $100.78K derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | $33.82K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $67.64K derived: sum of 2 quarters · filed 2022-03-31 | $121.71K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $33.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $87.89K 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $54.07K 10-Q · filed 2021-08-23 |